SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AbbVie Seeks FDA Approval for Etentamig

AbbVie filed a biologics license application for etentamig, seeking FDA approval for multiple myeloma.

ABBV

Related stories